| Robert Bruce Moricca, MD | |
|
320 Superior Ave, Suite 200, Newport Beach, CA 92663-2741 | |
| (949) 642-6200 | |
| (949) 642-9359 |
| Full Name | Robert Bruce Moricca |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 43 Years |
| Location | 320 Superior Ave, Newport Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902815822 | NPI | - | NPPES |
| G49411 | Other | LICENSE | |
| GR0077190 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | G49411 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoag Memorial Hospital Presbyterian | Newport beach, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newport Pulmonary Associates | 7911941513 | 4 |
News Archive
Dr. Richard "Rich" Edwards got a look at his new hands for the first time today when all the bandages were removed so doctors could evaluate how the hands are doing. A team of surgeons from Kleinert Kutz and Associates and the University of Louisville performed a double hand transplant on the Oklahoma resident during a 17 ½ hour surgical procedure beginning August 24 at the Jewish Hospital Hand Care Center.
Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.
The HEALTHY FUTURES project developed an online interactive atlas that maps and predicts the risk in eastern Africa of three deadly tropical diseases: malaria and Rift Valley fever, both transmitted by mosquitos, and schistosomiasis, which is caused by worms that emerge from freshwater snails.
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.
› Verified 1 days ago
| Entity Name | Newport Pulmonary Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114936010 PECOS PAC ID: 7911941513 Enrollment ID: O20050614001456 |
News Archive
Dr. Richard "Rich" Edwards got a look at his new hands for the first time today when all the bandages were removed so doctors could evaluate how the hands are doing. A team of surgeons from Kleinert Kutz and Associates and the University of Louisville performed a double hand transplant on the Oklahoma resident during a 17 ½ hour surgical procedure beginning August 24 at the Jewish Hospital Hand Care Center.
Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.
The HEALTHY FUTURES project developed an online interactive atlas that maps and predicts the risk in eastern Africa of three deadly tropical diseases: malaria and Rift Valley fever, both transmitted by mosquitos, and schistosomiasis, which is caused by worms that emerge from freshwater snails.
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.
› Verified 1 days ago
| Entity Name | Mesa Pulmonary Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821610874 PECOS PAC ID: 3476975087 Enrollment ID: O20200626000542 |
News Archive
Dr. Richard "Rich" Edwards got a look at his new hands for the first time today when all the bandages were removed so doctors could evaluate how the hands are doing. A team of surgeons from Kleinert Kutz and Associates and the University of Louisville performed a double hand transplant on the Oklahoma resident during a 17 ½ hour surgical procedure beginning August 24 at the Jewish Hospital Hand Care Center.
Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.
The HEALTHY FUTURES project developed an online interactive atlas that maps and predicts the risk in eastern Africa of three deadly tropical diseases: malaria and Rift Valley fever, both transmitted by mosquitos, and schistosomiasis, which is caused by worms that emerge from freshwater snails.
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Bruce Moricca, MD 320 Superior Ave, Suite 200, Newport Beach, CA 92663-2741 Ph: (949) 642-6200 | Robert Bruce Moricca, MD 320 Superior Ave, Suite 200, Newport Beach, CA 92663-2741 Ph: (949) 642-6200 |
News Archive
Dr. Richard "Rich" Edwards got a look at his new hands for the first time today when all the bandages were removed so doctors could evaluate how the hands are doing. A team of surgeons from Kleinert Kutz and Associates and the University of Louisville performed a double hand transplant on the Oklahoma resident during a 17 ½ hour surgical procedure beginning August 24 at the Jewish Hospital Hand Care Center.
Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared with standard treatment for diabetes, reports Dr Viveca Ritsinger from the Unit of Cardiology of the Department of Medicine, Karolinska Institute, Stockholm, Sweden and colleagues in The Lancet Diabetes & Endocrinology.
The HEALTHY FUTURES project developed an online interactive atlas that maps and predicts the risk in eastern Africa of three deadly tropical diseases: malaria and Rift Valley fever, both transmitted by mosquitos, and schistosomiasis, which is caused by worms that emerge from freshwater snails.
An online service that positions itself as the "Craigslist of biospecimens" aims to eliminate one of the most costly bottlenecks in biomedical R&D - delays in obtaining specimens suitable for research.
Zeltia announces today that its pharmaceutical division PharmaMar will start a Phase III trial with PM1183 in combination with doxorubicin against topotecan in SCLC, given the activity observed in an interim analysis of an ongoing Phase Ib trial. The results of this study will be presented at a prominent international cancer meeting this year, which will be soon announced.
› Verified 1 days ago
Dr. Sevitlana Safaei, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Superior Ave, Ste 205, Newport Beach, CA 92663 Phone: 949-650-2462 Fax: 949-650-1366 | |
Dr. Jin-hwa Simon, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Brian Kong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Cesar Balbin Guerrero, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 350 Vista Madera, Newport Beach, CA 92660 Phone: 949-270-6371 | |
Nhat Tran, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Leslie Kennerly Meserve, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Newport Center Dr Ste 310, Newport Beach, CA 92660 Phone: 949-558-0501 Fax: 949-558-0502 | |
Bhavini Jashvant Jaiswal, M.D Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Critical Care Department Box 6100, Newport Beach, CA 92663 Phone: 480-227-1318 |